Masoud Maleki

Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL)

Ghada Kchour, Mahdi Tarhini, Hiba El Hajj et al. · Blood · 2009 · 188 citations · Full text

Medicine, Hematology, Pharmacology +11

Association between miR-146a C > G, miR-149 T > C, miR-196a2 T > C, and miR-499 A > G polymorphisms and susceptibility to idiopathic recurrent pregnancy loss

Meysam Alipour, Maryam Abtin, Asghar Hosseinzadeh et al. · Journal of Assisted Reproduction and Genetics · 2019 · 28 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Preparation of a nanovaccine against <i>Brucella melitensis</i> M16 based on PLGA nanoparticles and oligopolysaccharide antigen

Masoud Maleki, Mojtaba Salouti, Mehdi Shafiee Ardestani et al. · Artificial Cells Nanomedicine and Biotechnology · 2019 · 23 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immunogenicity evaluating of the SLNs-alginate conjugate against Pseudomonas aeruginosa

Hossein Afshari, Masoud Maleki, Mozhdeh Hakimian et al. · Journal of Immunological Methods · 2020 · 22 citations

Life Sciences, Immunology, Microbiology +10

Immunological effects of two new nanovaccines against Brucella based on OPS and LPS antigens conjugated with PLGA nanoparticles

Hossein Afshari, Masoud Maleki, Mojtaba Salouti · European Polymer Journal · 2020 · 19 citations

Life Sciences, Immunology, Infectious Diseases +17